Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001209191-10-039277)

Filing Details

Accession Number:: 0001209191-10-039277
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2010-07-21 13:00:00
Reporting Period:: 2010-07-19

Filing Date:: 2010-07-21
Accepted Time:: 2010-07-21 18:56:15
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1390478	Rxi Pharmaceuticals Corp	RXII	Pharmaceutical Preparations (2834)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1460224	Ramani Varanasi	C/O Rxi Pharmaceuticals Corporation 60 Prescott Street Worcester MA 01605	Vp Business Development	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2010-07-19	5,000	$2.05	5,558	No	4	S	Direct
Common Stock	Acquisiton	2010-07-19	5,600	$2.04	11,158	No	4	A	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct
No	4	A	Direct

Footnotes

The sale price reported in this Form 4 was between the range of $2.05 per share and $2.05432 per share. Full information regarding the number of shares sold at each seperate price will be provided to the Commission staff upon request.